Literature DB >> 16289784

Involvement of PKA, MAPK/ERK and CaMKII, but not PKC in the acute antidepressant-like effect of memantine in mice.

Rúbia C Almeida1, Daniela G Souza, Rossana C Soletti, Manuela G López, Ana Lúcia S Rodrigues, Nelson H Gabilan.   

Abstract

This study investigated the cellular signaling pathways involved in the acute antidepressant-like action of memantine in the forced swimming test (FST) in mice. The immobility time in the FST was reduced by memantine (3-10 mg/kg, i.p.). The anti-immobility effect of memantine (3 mg/kg, i.p.) was prevented by pretreatment with H-89 (1 microg/site, i.c.v., an inhibitor of PKA), PD098059 (5 microg/site, i.c.v., an inhibitor of MAPK/ERK), KN-62 (1 microg/site, i.c.v., an inhibitor of CaMKII), but not with chelerythrine (1 microg/site, i.c.v., an inhibitor of PKC). Taken together, these results firstly demonstrate that the acute antidepressant-like effect of memantine seems to be dependent on the cellular signaling modulated by PKA, CaMKII and MAPK/ERK, but not by PKC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16289784     DOI: 10.1016/j.neulet.2005.10.057

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  17 in total

1.  Blockade of the KATP channel Kir6.2 by memantine represents a novel mechanism relevant to Alzheimer's disease therapy.

Authors:  S Moriguchi; T Ishizuka; Y Yabuki; N Shioda; Y Sasaki; H Tagashira; H Yawo; J Z Yeh; H Sakagami; T Narahashi; K Fukunaga
Journal:  Mol Psychiatry       Date:  2016-10-25       Impact factor: 15.992

2.  Glutamatergic system and mTOR-signaling pathway participate in the antidepressant-like effect of inosine in the tail suspension test.

Authors:  Filipe Marques Gonçalves; Vivian Binder Neis; Débora Kurrle Rieger; Tanara V Peres; Mark William Lopes; Isabella A Heinrich; Ana Paula Costa; Ana Lúcia S Rodrigues; Manuella P Kaster; Rodrigo Bainy Leal
Journal:  J Neural Transm (Vienna)       Date:  2017-07-10       Impact factor: 3.575

Review 3.  Opioid modulation of cognitive impairment in depression.

Authors:  Moriah L Jacobson; Hildegard A Wulf; Caroline A Browne; Irwin Lucki
Journal:  Prog Brain Res       Date:  2018-09-18       Impact factor: 2.453

4.  Modulation of PKA, PKC, CAMKII, ERK 1/2 pathways is involved in the acute antidepressant-like effect of (octylseleno)-xylofuranoside (OSX) in mice.

Authors:  Lucimar M Pinto Brod; Mariana G Fronza; Jaqueline Pinto Vargas; Diogo S Lüdtke; César Augusto Brüning; Lucielli Savegnago
Journal:  Psychopharmacology (Berl)       Date:  2016-12-19       Impact factor: 4.530

5.  Signaling pathways underlying the antidepressant-like effect of inosine in mice.

Authors:  Filipe Marques Gonçalves; Vivian Binder Neis; Débora Kurrle Rieger; Mark William Lopes; Isabella A Heinrich; Ana Paula Costa; Ana Lúcia S Rodrigues; Manuella P Kaster; Rodrigo Bainy Leal
Journal:  Purinergic Signal       Date:  2016-12-13       Impact factor: 3.765

6.  NMDA receptor/nitrergic system blockage augments antidepressant-like effects of paroxetine in the mouse forced swimming test.

Authors:  Mehdi Ghasemi; Laleh Montaser-Kouhsari; Hamed Shafaroodi; Behtash Ghazi Nezami; Farzad Ebrahimi; Ahmad Reza Dehpour
Journal:  Psychopharmacology (Berl)       Date:  2009-07-16       Impact factor: 4.530

7.  Combined use of pregabalin and memantine in fibromyalgia syndrome treatment: a novel analgesic and neuroprotective strategy?

Authors:  Jill M Recla; Constantine D Sarantopoulos
Journal:  Med Hypotheses       Date:  2009-04-10       Impact factor: 1.538

8.  Cyclic GMP-mediated memory enhancement in the object recognition test by inhibitors of phosphodiesterase-2 in mice.

Authors:  Lindsay M Lueptow; Chang-Guo Zhan; James M O'Donnell
Journal:  Psychopharmacology (Berl)       Date:  2015-11-02       Impact factor: 4.530

Review 9.  Neuronal correlates of depression.

Authors:  Dipesh Chaudhury; He Liu; Ming-Hu Han
Journal:  Cell Mol Life Sci       Date:  2015-11-05       Impact factor: 9.261

10.  Pharmacodynamics of memantine: an update.

Authors:  G Rammes; W Danysz; C G Parsons
Journal:  Curr Neuropharmacol       Date:  2008-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.